HeraMED Limited (ASX:HMD)
Australia
· Delayed Price · Currency is AUD 0.0410
-0.0010 (-2.38%)
At close: Mar 6, 2026
HeraMED Company Description
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States.
It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care.
The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
HeraMED Limited
| Country | Australia |
| Founded | 2011 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Anoushka Gungadin |
Contact Details
Address: 117 Camberwell Road Hawthorn East, VIC 3123 Australia | |
| Phone | 61 2 7251 1888 |
| Website | hera-med.com |
Stock Details
| Ticker Symbol | HMD |
| Exchange | Australian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | AUD |
| ISIN Number | AU0000028367 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Anoushka Gungadin | MD, Chief Executive Officer and Director |
| Cameron Peter Jones C.A. | Chief Financial Officer and Company Secretary |
| Henry Jordan | Head of Investor Relations |
| Dr. Arturo Weschler M.D. | C.M.O |
| Dr. Mandy Khaira | Chief Clinical Transformation Officer and Chief Medical Officer |
| Stephanie Vipond | Joint Company Secretary |